Karyopharm Therapeutics (KPTI) Earnings Date & Reports

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

KPTI is expected to report earnings to rise 8.33% to -25 cents per share on May 01

Karyopharm Therapeutics KPTI Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Beat

by $0.01

Q3'24

Est.

$-0.26

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.01

The last earnings report on February 19 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 179.12K shares outstanding, the current market capitalization sits at 34.17M.

View a ticker or compare two or three

Compare

KPTI